## Abstract ## Background The current study aimed to evaluate the significance of the cell‐cycle‐control proteins cyclin D1 and p16 as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with docetaxel and radiotherapy. ## Methods Cyclin D1 and/or p16 protein exp
Prognostic significance of p16 in locally advanced squamous cell carcinoma of the head and neck treated with concurrent cisplatin and radiotherapy
✍ Scribed by Harold Y. Lau; Sony Brar; Alexander C. Klimowicz; Stephanie K. Petrillo; Desirée Hao; Nigel T. Brockton; Christina S. Kong; Susan P. Lees-Miller; Anthony M. Magliocco
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 328 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Human papillomavirus (HPV)–related squamous cell cancer of the head and neck (SCCHN) has emerged as a distinct clinical entity. The expression of p16 protein can be used as a surrogate for HPV status.
Methods
p16 immunohistochemistry (IHC) was assessed in archival paraffin‐embedded material for 55 patients with locally advanced SCCHN treated with a uniform regimen of cisplatin and radiation. HPV status was assessed by colorimetric in situ hybridization (CISH) and polymerase chain reaction (PCR).
Results
Compared with p16‐ and HPV‐negative patients, the p16‐ and HPV‐positive patients had improved overall survival, disease‐free survival, and locoregional recurrence rates.
Conclusions
p16 IHC may serve as a useful surrogate and prognostic marker for patients with HPV‐related SCCHN treated with cisplatin and radiation. © 2010 Wiley Periodicals, Inc. Head Neck, 2011
📜 SIMILAR VOLUMES
## Abstract ## Background. Induction chemotherapy may contribute to decreased local and distant recurrences in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) resectable for cure. ## Methods. Patients with previously untreated locally advanced stage III–IV (N0
Background. Our center sought to implement a simple chemoradiotherapy schedule for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) with minimal toxicity to achieve rates of overall survival comparable to other schedules. Methods. The chemoradiotherapy schedule co
## Abstract ## Background This study was established to determine the maximum tolerated dose of intra‐arterial cisplatin (IAC) concurrent with accelerated fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma (HNSCC). ## Methods We conducted a phase I study. Treat
## Abstract The __p16__^INK4a^ gene, localized within chromosome 9p21, has been identified as a cyclin‐dependent kinase inhibitor and may negatively regulate the cell cycle acting as a tumor suppressor. Genetic alterations involving the 9p21 region are common in human cancers. A consecutive series